AJMC November 15, 2024
Kennedy Ferruggia

Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.

This article was originally published on Pharmacy Times®.

A new study findings published in The Lancet assessed the effectiveness of respiratory syncytial virus (RSV) vaccines against RSV-associated hospitalizations and emergency department encounters among individuals at least 60 years of age. The study was conducted to confirm RSV vaccine effectiveness found in clinical trials against lower respiratory tract disease using real world data.1

According to the CDC, the US experiences up to 160,000 hospitalizations and around 10,000 deaths among older adults due to RSV infection each year. Symptoms typically present like a mild cold but could become more severe...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Health System / Hospital, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
Mpox Clade I in the U.S. Should Be a Wake-Up Call
Journalists Address HHS Under Trump, Rural PFAS Contamination, and Bird Flu
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.
It's sick season. Here's how to protect yourself from norovirus, COVID-19, flu and RSV
China marks muted 5th anniversary of first COVID death

Share This Article